دانلود کتاب Brain Tumor: Research and Therapy

فهرست مطالب :

Front Matter....Pages II-XIV
Front Matter....Pages 1-1
Histopathological Classification of Brain Tumors According to the Revised WHO Classification: Current State and Perspectives....Pages 3-20
Histological Aspects of Certain Benign Brain Tumors: Review of Current Topics....Pages 21-27
The Statistical Analysis of Prognostic Factors for Brain Tumors....Pages 29-38
Evaluation of Histological Grading Systems of Astrocytic Tumors....Pages 39-44
Histological and Radioimaging Study of Malignant Change in Low-Grade Astrocytoma....Pages 45-49
Clinicopathological Study of Mixed Oligoastrocytoma....Pages 51-60
Metallothionein in Gliomas....Pages 61-67
Histological Grading of Meningioma Based on MIB-1 Immunoreactivity....Pages 69-78
Incidental Meningiomas in Autopsy Cases in Computed Tomography and Magnetic Resonance Imaging Era....Pages 79-88
Clinicopathological Study of Malignant Meningiomas....Pages 89-99
Front Matter....Pages 101-101
Expression of L1CAM in Brain Tumors: Immunohistochemical Study Using Anti-L1CAM Antibodies....Pages 103-107
Expression and Biological Functions of L1 Cell Adhesion Molecule in Malignant Glioma Cells....Pages 109-118
The Role of Urokinase-Type Plasminogen Activator in the Invasion and Proliferation of Malignant Brain Tumors....Pages 119-125
Stemline Study Based on the Nuclear Characterization and Image Cytometry in Resected Brain Tumors....Pages 127-140
Efficiency of Glioma Score in Glioma Patients Using Proliferating Potential with MIB-1 Monoclonal Antibody....Pages 141-148
Front Matter....Pages 149-149
Molecular Analysis of Phosphorylated Tyrosine-Binding Proteins in the Transduction of Proliferation and Differentiation Signals....Pages 151-159
Gene Alterations in Glial Tumors....Pages 161-172
A Model for the Molecular Pathogenesis of Astrocytic Gliomas....Pages 173-186
Molecular Genetics of Oligodendroglial Tumors....Pages 187-201
The Correlation Between flg Gene Expression and the Progression of Glioma....Pages 203-209
Front Matter....Pages 149-149
Expression of trk Proto-Oncogene Product in Medulloblastoma....Pages 211-220
Differential Expression of FGF Receptor-1 and FGF Receptor-2 Is Associated with Malignant Progression of Gliomas....Pages 221-232
Point Mutations of Epidermal Growth Factor Receptor Transcripts in Primary Human Malignant Gliomas....Pages 233-236
Expression of Vascular Endothelial Growth Factor in Human Brain Tumors In Vivo....Pages 237-245
Studies of Retinoblastoma and p53 Gene Mutations in Human Astrocytomas....Pages 247-253
Immunohistochemical Assessments of P53 Protein Accumulation and Tumor Growth Fraction During the Progression of Astrocytomas....Pages 255-262
Homozygous Deletion of the p16 Gene in Malignant Glioma....Pages 263-268
Detection of Binding Proteins of Merlin, the NF2 Tumor Suppressor Gene Product....Pages 269-276
Mutations and Loss of Heterozygosity of the von Hippel-Lindau Tumor Suppressor Gene in Sporadic Central Nervous System Hemangioblastomas....Pages 277-282
Anti-Fas Antibody Induces Apoptosis in Cultured Glioma Cells by Activation of the Sphingomyelin Pathway....Pages 283-291
Induction of Apoptosis in Malignant Glioma Cells by Anti-Fas Antibody....Pages 293-301
Front Matter....Pages 303-303
Monocyte Chemoattractant Protein-1 (MCP-1) Derived from Brain Tumors: Its Significance and Clinical Application....Pages 305-313
Experimental Analysis of Proto-Oncogene and Histocompatibility Antigen Gene Expression During Brain Tumor Progression....Pages 315-325
Suppressed Expression of T-Cell Costimulatory Molecules B7 and B70 in Human Glioblastomas In Vivo....Pages 327-337
Clinical Trials with Interferon-Alpha as a Chemosensitizer in Gliomas....Pages 339-347
Evaluation of Interferon Therapy on Malignant Gliomas....Pages 349-361
Clinical Results of Specific Targeting Therapy Against Patients with Malignant Glioma....Pages 363-370
Structural Analysis of Anti-cancer Antibody, CLN-IgG, and Anti-Idiotypic Antibody, Idio-No. 3, for the Study of Idiotope Image Transmission: An Insight into Antigen-Specific Human Monoclonal Antibody Therapy....Pages 371-379
Clinical Effect of CLN-IgG on Glioma and Its Correlation with the Induction of Antianti-Idiotypic Antibody in the Serum....Pages 381-387
Gene Therapy for Central Nervous System Tumors....Pages 389-396
Front Matter....Pages 303-303
Application of the Apoptotic Gene to Gene Therapy of Malignant Gliomas....Pages 397-407
Experimental Therapy for Malignant Brain Tumors Using Genetically Engineered Herpes Simplex Virus Type 1....Pages 409-414
Investigations of Retroviral-Mediated Gene Therapy for Malignant Glioma: Transduction with HTK-Bearing Retroviruses Sensitizes Glioma Cells to Ganciclovir....Pages 415-421
Cytokine Gene Therapy of Malignant Glioma by Means of DNA/Liposomes....Pages 423-434
Analysis of sdi-1 Gene Functions in Human Malignant Gliomas....Pages 435-440
Antisense DNA Approach to the Growth of Human Glioma Cells....Pages 441-447
Back Matter....Pages 449-456